An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors

Article Tools

• Email

  Thank you for your interest in spreading the word about Science.

  NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

  Your Email

  Your Name

  Send To

  Enter multiple addresses on separate lines or separate them with commas.

  You are going to email the following An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors

  Message Subject (Your Name) has forwarded a page to you from Science

  Message Body (Your Name) thought you would like to see this page from the Science web site.

  Your Personal Message

  CAPTCHA

  This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

  Send Message
• Download Powerpoint
• Print
• Alerts

  Please log in to add an alert for this article.

  Log In with your AAAS ID

  Sign In to Email Alerts with your Email Address

  Email

  Log in
• Citation tools

  An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors

  By Katharina Reinhard, Benjamin Rengstl, Petra Oehm, Kristina Michel, Arne Billmeier, Nina Hayduk, Oliver Klein, Kathrin Kuna, Yasmina Ouchan, Stefan Wöll, Elmar Christ, David Weber, Martin Suchan, Thomas Bukur, Matthias Birtel, Veronika Jahndel, Karolina Mroz, Kathleen Hobohm, Lena Kranz, Mustafa Diken, Klaus Kühlcke, Özlem Türeci, Ugur Sahin

  Science24 Jan 2020 : 446-453

  A nanoparticle RNA vaccine strategy targets chimeric antigen receptor (CAR)–T cells to solid tumors in difficult-to-treat mouse models.

  • Supplementary Materials

  Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
• Share

  An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors

  By Katharina Reinhard, Benjamin Rengstl, Petra Oehm, Kristina Michel, Arne Billmeier, Nina Hayduk, Oliver Klein, Kathrin Kuna, Yasmina Ouchan, Stefan Wöll, Elmar Christ, David Weber, Martin Suchan, Thomas Bukur, Matthias Birtel, Veronika Jahndel, Karolina Mroz, Kathleen Hobohm, Lena Kranz, Mustafa Diken, Klaus Kühlcke, Özlem Türeci, Ugur Sahin

  Science24 Jan 2020 : 446-453

  A nanoparticle RNA vaccine strategy targets chimeric antigen receptor (CAR)–T cells to solid tumors in difficult-to-treat mouse models.

  • Supplementary Materials

  Share This Article: Copy